School of Pharmacy, Anhui Medical University, Hefei, PR China.
Engineering Research Center of Biomass Conversion and Pollution Prevention of Anhui Educational Institutions, Fuyang Normal University, Fuyang, PR China.
J Enzyme Inhib Med Chem. 2020 Dec;35(1):773-785. doi: 10.1080/14756366.2020.1740693.
Basis on molecular docking and pharmacophore analysis of naphthoquinone moiety, a total of 23 compounds were designed and synthesised. With the help of reverse targets searching, anti-cancer activity was preliminarily evaluated, most of them are effective against some tumour cells, especially compound : 1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-en-1-yl-4-oxo-4-((4-phenoxyphenyl)amino) butanoate whose IC against SGC-7901 was 4.1 ± 2.6 μM. Meanwhile the anticancer mechanism of compound had been investigated by AnnexinV/PI staining, immunofluorescence, Western blot assay and molecular docking. The results indicated that this compound might induce cell apoptosis and cell autophagy through regulating the PI3K signal pathway.
基于萘醌部分的分子对接和药效团分析,共设计和合成了 23 种化合物。借助反向靶标搜索,初步评估了它们的抗癌活性,其中大多数对某些肿瘤细胞有效,特别是化合物:1-(5,8-二羟基-1,4-二氧代-1,4-二氢萘-2-基)-4-甲基戊-3-烯-1-基-4-氧代-4-((4-苯氧基苯基)氨基)丁基-4-氧代丁酸酯,其对 SGC-7901 的 IC 值为 4.1±2.6μM。同时,通过 AnnexinV/PI 染色、免疫荧光、Western blot 检测和分子对接研究了化合物的抗癌机制。结果表明,该化合物可能通过调节 PI3K 信号通路诱导细胞凋亡和细胞自噬。